id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2019-N-5405-0004,FDA,FDA-2019-N-5405,New Animal Drugs; Withdrawal of Approval of New Animal Drug Applications,Rule,Withdrawal,2021-02-23T05:00:00Z,2021,2,2021-02-23T05:00:00Z,,2021-02-23T14:13:24Z,2021-03250,0,0,0900006484a48841
FDA-2019-N-5405-0005,FDA,FDA-2019-N-5405,New Animal Drug Applications; BetaAminopropionitrile Fumarate; n-Butyl Chloride; Cupric Glycinate Injection; Dichlorophene and Toluene; Orgotein for Injection; Tetracycline Tablets,Rule,Final Rule,2021-02-23T05:00:00Z,2021,2,2021-02-23T05:00:00Z,,2021-02-23T15:22:10Z,2021-03251,0,0,0900006484a48d27
FDA-2019-N-5405-0001,FDA,FDA-2019-N-5405,"Alaco, Inc., et al.; Proposal To Withdraw Approval of Seven New Animal Drug Applications; Opportunity for a Hearing",Notice,Withdrawal,2020-01-08T05:00:00Z,2020,1,2020-01-08T05:00:00Z,2020-03-10T03:59:59Z,2020-01-14T02:02:15Z,2020-00072,0,0,090000648427befa